Tag: exudative armd

COVID Delay of nAMD Treatment Less Harmful than Expected

Many people with neovascular age-related macular degeneration (nAMD) lost less vision than expected during treatment delays imposed by COVID-19, researchers say. The finding suggests that...

Ranibizumab Biosimilar Shows Equivalent Efficacy to Branded Drug for Neovascular AMD

NEW YORK (Reuters Health) – In a phase 3 study, the ranibizumab biosimilar SB11 demonstrated equivalent efficacy and similar safety and immunogenicity profiles compared with...

Implant Reduces Treatment Burden in Wet Macular Degeneration

A ranibizumab implant (Port Delivery System) could ease treatment burden, and even improve long-term visual acuity, in people with neovascular age-related macular degeneration, interim results...

Pandemic Delays Treatment, Threatening Patients and Research

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The COVID-19 pandemic has taken a severe toll on patients with...